中国药房2024,Vol.35Issue(20) :2565-2570.DOI:10.6039/j.issn.1001-0408.2024.20.21

抗侵袭性真菌病治疗药物监测的研究进展

Advances in therapeutic drug monitoring of invasive fungal disease

陈钰婷 武正华 范国荣
中国药房2024,Vol.35Issue(20) :2565-2570.DOI:10.6039/j.issn.1001-0408.2024.20.21

抗侵袭性真菌病治疗药物监测的研究进展

Advances in therapeutic drug monitoring of invasive fungal disease

陈钰婷 1武正华 2范国荣1
扫码查看

作者信息

  • 1. 上海大学医学院,上海 200444;上海交通大学医学院附属第一人民医院临床药学科,上海 200080
  • 2. 上海交通大学医学院附属第一人民医院临床药学科,上海 200080
  • 折叠

摘要

侵袭性真菌病(IFD)是一种深部感染性疾病,在血液系统恶性肿瘤患者中的发病率总体呈上升趋势.三唑类、多烯类、棘白菌素类抗真菌药物以及5-氟胞嘧啶和复方磺胺甲噁唑是临床治疗IFD的主要药物.对这些药物开展治疗药物监测有助于保证药物疗效、减少不良反应的发生.本文系统概述了以上5类药物的有效血药浓度范围,以及血药浓度与疗效和不良反应之间的相关性.固相萃取联合超高效液相色谱串联质谱技术在该研究领域是一种较有前景的检测方法.

Abstract

Invasive fungal disease(IFD)is a deep infectious disease with an overall increasing incidence in patients with hematologic malignancies.Triazoles,polyenes,echinocandins echinocandin antifungal drugs,5-fluorocytosine and Compound sulfamethoxazole are the main drugs used in the clinical treatment of IFD.Therapeutic drug monitoring for IFD prevention and treatment is helpful to optimize treatment outcomes and reduce adverse effects.In this paper,the effective plasma concentration ranges of the above 5 types of drugs are systematically summarized,and the correlation between the plasma concentration of antifungal drugs and the efficacy and adverse reactions is reviewed.Solid phase extraction combined with ultra-performance chromatography-tandem mass spectrometry is a promising detection method in this research field.

关键词

造血干细胞移植/血液系统恶性肿瘤/侵袭性真菌病/治疗药物监测/检测方法

Key words

hematopoietic stem cell transplantation/hematologic malignancies/invasive fungal disease/therapeutic drug monitoring/analytical methods

引用本文复制引用

基金项目

国家自然科学基金项目(81973289)

出版年

2024
中国药房
中国医院协会,中国药房杂志社

中国药房

CSTPCD北大核心
影响因子:0.956
ISSN:1001-0408
段落导航相关论文